Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FW5KA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,142
Award facts
- Contract value 100% obligated
- $10,142.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $10,142.35 delivery order to AmerisourceBergen Drug Corp on May 19, 2026, for RINVOQ ER 15 mg tablets (30-count unit dose). The order ceiling is $10,142.35 with ultimate completion on May 20, 2026.
Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside applied.
Quick answers
Who was awarded contract SPE2DR26FW5KA?
SPE2DR26FW5KA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 19, 2026.
How much is contract SPE2DR26FW5KA worth?
The government has obligated $10,142 on SPE2DR26FW5KA.
Is contract SPE2DR26FW5KA an order under another contract?
Yes. SPE2DR26FW5KA is a delivery order under SPE2DR25D7067, an indefinite delivery contract.
Was contract SPE2DR26FW5KA competed?
The extent of competition for SPE2DR26FW5KA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award